Free Trial
→ The election trade you can't lose (From Investors Alley) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 9 of 15

Slide 9
Back to 8
Continue to 10
 
Back to 8
Continue to 10
 

Revolution Medicines (NASDAQ:RVMD)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
12 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$52.92 (16.5% Upside)

About Revolution Medicines

Revolution Medicines logoRevolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$56.00 ➝ $56.00
8/8/2024JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$55.00 ➝ $54.00
8/8/2024WedbushReiterated RatingOutperform ➝ Outperform$59.00 ➝ $59.00
8/8/2024Needham & Company LLCLower Price TargetBuy ➝ Buy$62.00 ➝ $61.00
7/18/2024BarclaysBoost Price TargetOverweight ➝ Overweight$52.00 ➝ $54.00
7/16/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$45.00 ➝ $55.00
7/16/2024Bank of AmericaBoost Price TargetBuy ➝ Buy$48.00 ➝ $55.00
7/16/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$46.00 ➝ $62.00
7/16/2024HC WainwrightBoost Price TargetBuy ➝ Buy$44.00 ➝ $56.00
7/12/2024BarclaysInitiated CoverageOverweight$52.00
Slide 9
Back to 8
Continue to 10
 

Are You Ready for a Small-Cap Rally? (Ad)

Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt industries worth over $46 trillion. What's even more intriguing?

Click here to uncover how you can get in on the ground floor.

More From MarketBeat
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”
Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...
Paradigm Press | Sponsored
20 "Past Their Prime" Stocks to Dump From Your Portfolio
Did you know the S&P 500 as we know it today does not look anything close to what it looked like 30 years ...
MarketBeat
How the US Will Win the Great Lithium Race
China spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...
DealMaker | Sponsored
15 REITs That Wall Street Analysts Love in Today's Market
There are more than 200 publicly-traded real-estate investment trusts (REITs) that you can buy through your br...
MarketBeat
Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. If you're planning on re...
Gold Safe Exchange | Sponsored
7 Nuclear Energy Stocks to Buy on Growing Demand
The question isn't if nuclear energy is making a comeback, but why? There are several answers, starting with t...
MarketBeat